UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.80
+0.50 (0.66%)
Jul 30, 2026, 12:36 PM CST

UnicoCell Biomed Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-109.59-114.84-93.07-84.11-91.16-86.37
Depreciation & Amortization
19.3420.2627.2526.1824.0925.53
Other Amortization
0.30.290.330.210.180.74
Loss (Gain) From Sale of Assets
----4.83--
Loss (Gain) From Sale of Investments
1.40.671.79---
Stock-Based Compensation
4.855.121.391.822.962.26
Provision & Write-off of Bad Debts
0.140.1200--
Other Operating Activities
-2.151.29-1.25-3.42-0.070.29
Change in Accounts Receivable
-0.37-0.5-0.73-0.7-0.980.36
Change in Inventory
-1.47-0.62-2.330.72-0.07-2.1
Change in Accounts Payable
0.23-0.751.87-0.810.84-0.4
Change in Unearned Revenue
-1.94-5.526.6-1.511.52-
Change in Other Net Operating Assets
2.673.17-3.360.9-0.92-2.02
Operating Cash Flow
-86.58-91.31-61.52-65.55-63.6-61.71
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3.98-5.5-5.32-15.8-14.45-23.64
Sale of Property, Plant & Equipment
---6.16--
Sale (Purchase) of Intangibles
-0.23-0.23-0.38-0.18-0.16-0.36
Investment in Securities
-164.8-167.9-117.35-297.14-150.08-0.08
Other Investing Activities
-0.140.71-0.24-0.30.27
Investing Cash Flow
-169.01-173.49-122.35-307.2-164.99-23.8

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--6.22-6.09-6.04-7.82-9.37
Net Debt Issued (Repaid)
-6.25-6.22-6.09-6.04-7.82-9.37
Issuance of Common Stock
179.79302.29179.85344.88159.043.71
Other Financing Activities
---0.220.170.15-
Financing Cash Flow
173.54296.07173.54339.01151.38-5.66

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-82.0431.27-10.33-33.74-77.21-91.17

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-90.56-96.81-66.84-81.35-78.05-85.34
Free Cash Flow Growth
------
Free Cash Flow Margin
-341.27%-321.59%-209.66%-330.82%-542.15%-1043.70%
Free Cash Flow Per Share
-1.46-1.59-1.17-1.51-1.88-2.27
Levered Free Cash Flow
-64.18-67.64-44.47-54.17-49.26-54.15
Unlevered Free Cash Flow
-63.37-66.8-43.56-53.27-48.47-53.74

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.311.341.461.451.260.66
Cash Income Tax Paid
-0.230.720.240.020.04
Change in Working Capital
-0.87-4.222.05-1.40.39-4.16